Injection Route and TLR9 Agonist Addition Significantly Impact Heroin Vaccine Efficacy | Molecular Pharmaceutics
Targeting TLR9 agonists to secondary lymphoid organs induces potent immune responses against HBV infection - ScienceDirect
PDF) CPG 7909, an Immunostimulatory TLR9 Agonist Oligodeoxynucleotide, as Adjuvant to Engerix-B� HBV Vaccine in Healthy Adults: A Double-Blind Phase I/II Study
Human TLR9 Agonist Kit | Stimulatory CpG ODNs | InvivoGen
CpG-C ODN M362 as an immunoadjuvant for HBV therapeutic vaccine reverses the systemic tolerance against HBV
Spherical nucleic acids as an infectious disease vaccine platform | PNAS
Optimization, Production, and Characterization of a CpG-Oligonucleotide-Ficoll Conjugate Nanoparticle Adjuvant for Enhanced Immunogenicity of Anthrax Protective Antigen | Bioconjugate Chemistry
Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19 | Scientific Reports
PDF) CPG 7909, an Immunostimulatory TLR9 Agonist Oligodeoxynucleotide, as Adjuvant to Engerix-B� HBV Vaccine in Healthy Adults: A Double-Blind Phase I/II Study
Toll-like receptor 9 activation by CpG oligodeoxynucleotide 7909 enhances the radiosensitivity of A549 lung cancer cells via the p53 signaling pathway
Frontiers | S-540956, a CpG Oligonucleotide Annealed to a Complementary Strand With an Amphiphilic Chain Unit, Acts as a Potent Cancer Vaccine Adjuvant by Targeting Draining Lymph Nodes
What are CpG ODNs and What is their Purpose? - Synbio Technologies
Sequences of synthesized CpG oligonucleotide. | Download Table
Full article: CPG-7909 (PF-3512676, ProMune®): toll-like receptor-9 agonist in cancer therapy
Frontiers | Class C CpG Oligodeoxynucleotide Immunomodulatory Response in Aged Squirrel Monkey (Saimiri Boliviensis Boliviensis)
Amphiphile-CpG vaccination induces potent lymph node activation and COVID-19 immunity in mice and non-human primates | npj Vaccines
Increased vaccine tolerability and protection via NF-κB modulation | Science Advances
TLR9-ERK-mTOR signaling is critical for autophagic cell death induced by CpG oligodeoxynucleotide 107 combined with irradiation in glioma cells | Scientific Reports
Human TLR9 Reporter THP-1 Cells | InvivoGen
A CpG Oligonucleotide Can Protect Mice from a Low Aerosol Challenge Dose of Burkholderia mallei | Infection and Immunity
A Review of the Role of CpG Oligodeoxynucleotides as Toll-Like Receptor 9 Agonists in Prophylactic and Therapeutic Vaccine Development in Infectious Diseases | SpringerLink
